Skip to content

Clinical trials

Completed Hemoglobinopathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemoglobinopathies Status: Completed Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20052
20061
20071
20083
20091
20101
20111
20155
20161
20174
20182
20192
20202
20212
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)4
University of California, San Francisco4
National Institute of Allergy and Infectious Diseases (NIAID)3
Bangladesh Bioscience Research Group2
Hillhurst Biopharmaceuticals, Inc.2
University of British Columbia2
Vertex Pharmaceuticals Incorporated2
Ann & Robert H Lurie Children's Hospital of Chicago1
Augusta University1
Bacha Khan Medical College1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemoglobinopathies41
Anemia, Sickle Cell24
Thalassemia18
Hematologic Diseases12
Anemia7
Immunologic Deficiency Syndromes7
beta-Thalassemia7
Fanconi Anemia4
Genetic Diseases, Inborn4
Hematologic Neoplasms4

Trials

Showing 51 to 41 of 41. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.